The challenge and promise of anti-epileptic therapy development in animal models.
about
Etiology matters - Genomic DNA Methylation Patterns in Three Rat Models of Acquired Epilepsy.Dual and Opposing Roles of MicroRNA-124 in Epilepsy Are Mediated through Inflammatory and NRSF-Dependent Gene Networks.Cannabinoids and Epilepsy.MicroRNA profiles in hippocampal granule cells and plasma of rats with pilocarpine-induced epilepsy--comparison with human epileptic samples.Screening of conventional anticonvulsants in a genetic mouse model of epilepsy.Evaluation of anticonvulsant and antinociceptive properties of new N-Mannich bases derived from pyrrolidine-2,5-dione and 3-methylpyrrolidine-2,5-dione.2014 Epilepsy Benchmarks Area III: Improve Treatment Options for Controlling Seizures and Epilepsy-Related Conditions Without Side EffectsAnti-inflammatory drugs in epilepsy: does it impact epileptogenesis?Disease modification in epilepsy: from animal models to clinical applications.Effects of antiepileptic drugs on interictal epileptiform discharges in focal epilepsies: an update on current evidence.Optogenetics enlightens neuroscience drug discovery.microRNA and Epilepsy.Circadian clustering of spontaneous epileptic seizures emerges after pilocarpine-induced status epilepticus.Animal Models of Seizures and Epilepsy: Past, Present, and Future Role for the Discovery of Antiseizure Drugs.Improving quality of science through better animal welfare: the NC3Rs strategy.Autism and Epilepsy: Exploring the Relationship Using Experimental Models.Neurology--the next 10 years.Meta-Analysis of MicroRNAs Dysregulated in the Hippocampal Dentate Gyrus of Animal Models of Epilepsy.Standardization procedure for plasma biomarker analysis in rat models of epileptogenesis: Focus on circulating microRNAs.Synthesis and Determination of Lipophilicity, Anticonvulsant Activity, and Preliminary Safety of 3-Substituted and 3-Unsubstituted N-[(4-Arylpiperazin-1-yl)alkyl]pyrrolidine-2,5-dione Derivatives.Identification and characterization of outcome measures reported in animal models of epilepsy: Protocol for a systematic review of the literature-A TASK2 report of the AES/ILAE Translational Task Force of the ILAE.Sodium selenate retards epileptogenesis in acquired epilepsy models reversing changes in protein phosphatase 2A and hyperphosphorylated tau.Recent Advances in Neonatal Seizures.Epilepsy an Update on Disease Mechanisms: The Potential Role of MicroRNAs.Systemic delivery of selective EP1 and EP3 receptor antagonists attenuates pentylenetetrazole-induced seizures in mice.Seizure-Suppressant and Neuroprotective Effects of Encapsulated BDNF-Producing Cells in a Rat Model of Temporal Lobe Epilepsy.New Tools for Epilepsy Therapy.Preclinical Animal Models for Dravet Syndrome: Seizure Phenotypes, Comorbidities and Drug Screening.
P2860
Q27316575-61B3C2DA-C40E-40E2-9FF8-52D7DE9BB87BQ27319868-4B091729-6B50-4479-8279-C04387AD6500Q27336451-27E27322-478C-43E6-852B-D977E38D39A6Q30665824-ACB132C6-2ACE-462D-9E27-F253EDEB45F4Q33646252-4D91C206-4A68-4345-900C-F70ADDE6F0E0Q36568597-C86FD088-D853-4556-B0E5-01718D90F09DQ37021062-A09B28AA-EE80-4D69-A89A-234AD9BFDEFEQ38341967-CA3CA697-A02C-4906-8907-A387E5C9556AQ38450069-50989406-F2E8-4F37-9089-F0E973373FA5Q38544921-F2AF49B7-9D5C-4E50-93CE-38CD39797A0AQ38650124-67C349C2-959E-4693-A44D-1F2218D4DF28Q38668244-4A06C6B1-A115-4C3E-9338-5365355287C8Q38679173-DB6D77A3-30ED-4824-BED6-29BA8E1658CAQ38746272-FB805EA4-4A9E-49EA-A725-1C7EE8702813Q38886703-C5BD9865-C737-4828-8E2A-764E9DC1DD2EQ41933122-9CCF8450-2BC1-4DC9-8BC0-E1CB6EE43C9DQ46374782-64634646-2AB1-43B7-9E56-BC09A5A9B58EQ47147411-CDEBA179-9F87-47A6-BAB8-4886AC8FBF38Q47568240-BFD48793-A8C5-4A0C-8D4D-F98A6502ABEDQ47633070-F757E57E-1B6D-4CA5-A098-73D39E76CD42Q47858417-8BFC1E0A-1436-4A2D-A78E-3B38DF02DD8FQ48003442-DD850B6E-5A96-43A4-84EC-6DA5EE13B15BQ50901686-41B4E427-A060-4C05-94B9-48E70D9642D1Q52332783-D7475F06-BBE9-46A4-AFB9-C945D6E89E6EQ52624388-E65FB121-136C-4CB4-B884-C7D40A0D807EQ54918000-CDCFC834-53D4-4018-82F1-5E3417578973Q54988377-54DD6733-7032-4CB2-B5D1-A8434AC4BA7CQ55471525-A2D71216-44FE-4C08-B10D-5BBBA1026B61
P2860
The challenge and promise of anti-epileptic therapy development in animal models.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 August 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The challenge and promise of anti-epileptic therapy development in animal models.
@en
The challenge and promise of anti-epileptic therapy development in animal models.
@nl
type
label
The challenge and promise of anti-epileptic therapy development in animal models.
@en
The challenge and promise of anti-epileptic therapy development in animal models.
@nl
prefLabel
The challenge and promise of anti-epileptic therapy development in animal models.
@en
The challenge and promise of anti-epileptic therapy development in animal models.
@nl
P2093
P2860
P50
P1433
P1476
The challenge and promise of anti-epileptic therapy development in animal models.
@en
P2093
Amy R Brooks-Kayal
Aristea S Galanopoulou
Asla Pitkanen
Frances E Jensen
Jerome Engel
Karen S Wilcox
Solomon L Moshé
P2860
P304
P356
10.1016/S1474-4422(14)70076-6
P577
2014-08-10T00:00:00Z